Composite dietary antioxidant index and the risk of colorectal cancer: Findings from the Singapore Chinese Health Study - PubMed (original) (raw)

. 2022 May 15;150(10):1599-1608.

doi: 10.1002/ijc.33925. Epub 2022 Jan 18.

Affiliations

Composite dietary antioxidant index and the risk of colorectal cancer: Findings from the Singapore Chinese Health Study

Yi-Chuan Yu et al. Int J Cancer. 2022.

Abstract

Colorectal cancer (CRC) is a major contributor to cancer death globally. Several studies showed some protections by certain individual dietary antioxidants against CRC development. Epidemiologic data on the composite dietary antioxidant index (CDAI) in relation to CRC risk are sparse. Using the Singapore Chinese Health Study, an ongoing prospective cohort consisting of 61 321 cancer-free participants aged 45 to 74 years at baseline, a food-based CDAI was calculated according to a previously established and validated method that included six food-sourced antioxidants including vitamins A, C and E, manganese, selenium and zinc. Cox proportional hazard regression method was used to estimate the hazard ratios (HRs) and their 95% confidence intervals (CIs) for CRC associated with various levels of CDAI with adjustment for multiple potential confounders. After an average of 17.5 years of follow-up, 2140 participants developed CRC. HRs (95% CIs) of CRC for quartiles 2, 3 and 4 of CDAI were 0.94 (0.83-1.07), 0.86 (0.75-1.00) and 0.80 (0.66-0.98), respectively, compared to the lowest quartile (Ptrend = .02). This inverse association between CDAI and CRC risk was more apparent in women or those without a history of diabetes, without family history of CRC, never smokers or overweight/obese individuals. However, none of the heterogeneity tests for the CDAI-CRC risk association reached statistical significance. Our findings suggest that food-based antioxidants may be beneficial for reducing the risk of CRC in the general population.

Keywords: antioxidant capacity; antioxidant score; colorectal cancer.

© 2022 UICC.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No conflict of interest was declared by any authors.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
    1. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. The Lancet. 2019;394(10207):1467–1480. - PubMed
    1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. - PubMed
    1. Teo MCC, Soo KC. Cancer Trends and Incidences in Singapore. Japanese Journal of Clinical Oncology. 2013;43(3):219–224. - PubMed
    1. Kuipers EJ, Grady WM, Lieberman D, et al. Colorectal cancer. Nature Reviews Disease Primers. 2015;1(1):15065. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources